Pletaal

Pletaal

cilostazol

Manufacturer:

Otsuka

Distributor:

Zuellig Pharma

Marketer:

Thai Otsuka
Concise Prescribing Info
Contents
Cilostazol
Indications/Uses
Prevention of recurrence of cerebral infarction (excluding cardiogenic cerebral embolism). Treatment of ischemic symptoms including ulcer, pain & coldness of the extremities, chronic arterial occlusion.
Dosage/Direction for Use
100 mg bid. Dosage adjusted to age of patient & severity of symptoms.
Administration
Should be taken on an empty stomach: Take at least 30 min before or 2 hr after meals.
Contraindications
Hemorrhage, CHF. Pregnant or possibly pregnant women, lactation.
Special Precautions
Patients on anticoagulant, antiplatelet or antithrombotic drugs; patients w/ bleeding tendency; during menstruation; severe hepatic or renal impairment.
Adverse Reactions
Headache, vertigo, GI discomfort, nausea, vomiting, soft stool, palpitation & rash.
Drug Interactions
Anticoagulants & other antiplatelet agents may increase bleeding tendency. Blood conc may be increased by CYP3A4 (eg, erythromycin) & CYP2C19 (eg, omeprazole) inhibitors.
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics) / Peripheral Vasodilators & Cerebral Activators
ATC Classification
B01AC23 - cilostazol ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Presentation/Packing
Form
Pletaal powd for oral liqd 0.5 g
Packing/Price
140 × 1's
Form
Pletaal tab 100 mg
Packing/Price
100's
Form
Pletaal tab 50 mg
Packing/Price
100's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in